REG - Deutsche Bank AG FF - Post-Stabilisation Notice

Deutsche Bank AGAnnouncement

03/06/2021 08:03

RNS Number : 6493A
  
Deutsche Bank AG, Frankfurt
  
03 June 2021
  
 

02 June 2021
 
 
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful
 
Grünenthal GmbH
Post-Stabilisation Notice
 
Pursuant to Article 6(3) of Commission Delegated Regulation (EU) 2016/1052 supplementing Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation, Deutsche Bank Aktiengesellschaft (contact: Jeremy Selway, telephone +44 (0)20 7547 5983) hereby gives notice that no stabilisation was undertaken by the Stabilising Manager named below in relation to the offer of the following securities.
 
 
Issuer:                                     Grünenthal GmbH                                        
 
Guarantor (if any):                  Grünenthal Pharma GmbH & Co. Kommanditgesellschaft, Grünenthal Italia S.r.l., Farmaceutici Formenti S.p.A.                    
 
Aggregate nominal amount:   EUR 650,000,000      
 
Description:                             EUR 400,000,000 Senior Secured Notes, 3.625% due 2026 (RegS ISIN: XS2337064856; 144A ISIN: XS2337065077); EUR 250,000,000 Senior Secured Notes, 4.125% due 2028 (RegS ISIN: XS2337703537; 144A ISIN: XS2337703610)    
 
Issue/Reoffer Price:               100    
 
Spread over benchmark:        423bps / 463bps
            
Stabilising Manager(s):           Deutsche Bank Aktiengesellschaft 
 
 
 
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
 
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
STAFFFVIRDIFIIL